Full Press Release Details
J.P. Morgan 40 th Annual Healthcare Conference January 2022
J.P. Morgan 40 th Annual Healthcare Conference January 2022
APRE
J.P. Morgan 40 th Annual Healthcare Conference January 2022 Forward - Looking Statements Certain information contained in this presentation includes "forward - looking statements", within the meaning of Section 27A of th
Key Takeaway: J.P. Morgan 40 th Annual Healthcare Conference January 2022
J.P. Morgan 40 th Annual Healthcare Conference January 2022
Price reaction · baseline $55.2 (2022-01-12 close) · hit after-hours · clean, no other APRE news in the window
day 0 close
-6.9%
day 1
-4.3%
day 3 · peak
-11.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+51%
120-day peak, hindsight
Typical move
5.9%
average across 7 past catalysts
Cash runway
~37 mo
Minimal dilution risk
Lead asset
APR-246+ azacitidine
Phase 3 · MDS